Four professionals in the BioRegion of Catalonia are among the 50 most influential leaders in Europe in the healthcare technology arena, according to HIMSS Europe. This international organization for the advancement of digitalization in healthcare, which organizes the event Health2.0, has published its ranking of the 50 Top Healthcare IT Leaders in Europe, which includes Manuel Armayones (UOC), Victor Bautista (SocialDiabetes), Inma Grau (Fundació iSYS and Hospital Clinic) and Jordi Serrano (UniversalDoctor).
Who will pay for my product? Who can kill it? How do I approach investors? What happens if I fail? Experts from CIMIT (Boston), the most experienced health accelerator in the world, share some of the lessons they’ve learned accelerating more than 600 healthtech projects in 15 years.
Co-Founder, CEO-CFO and Financial Chief of MJN Neuroserveis
Salva Gutiérrez is an economist and has a degree in Business Administration and Management. He is an investment and equity manager, with more than 25 years of experience in family offices. In 2012, with David Blánquez and Xavier Raurich, he founded MJN Neuroserveis, motivated by the daughter of one of the founders, who has epilepsy. They’ve developed a device to predict seizures in patients with this condition.
28% of all Catalan biomedical companies are created or headed up by women, and the percentage goes up to 46% for start-ups created over the past two years. 11 women entrepreneurs in the sector tell us about their experience and help raise awareness of cases like theirs to encourage other female scientists to follow their example.
Top bioentrepreneurship in Catalonia will share their personal experiences with students and researchers on 15, 22 and 29 May
Co-founder and CEO of Mediktor
Cristian Pascual has a degree in Industrial Engineering and an MBA from Esade and the Carlson School of Management. For 18 years, he held various executive positions at large companies in a variety of sectors. Then, in 2011, he founded Mediktor with Oscar García-Esquirol, a physician, intensive care specialists and medical soul of the project. “Now I am completely focused on revolutionizing the healthcare world,” says Pascual. Plus, he has been a business angel for the past 12 years and is involved in roughly 15 start-ups.
Publications in top journals, rounds of investment, licensing, benchmark events held in Barcelona... 2017 was a year full of good news for the BioRegion of Catalonia. Saying goodbye to the EMA and the political instability were the bittersweet counterpoint. What can we learn from these successes and failures? From research, enterprise and management, some of the main figures take stock.